Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    SUN PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
SUN PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,072316-   
Low Rs790228-   
Sales per share (Unadj.) Rs182.994.0-  
Earnings per share (Unadj.) Rs35.7-23.7-  
Cash flow per share (Unadj.) Rs46.2-19.6-  
Dividends per share (Unadj.) Rs11.500-  
Avg Dividend yield %1.20-  
Book value per share (Unadj.) Rs233.473.8-  
Shares outstanding (eoy) m2,399.34168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.12.9 175.9%   
Avg P/E ratio x26.1-11.5 -227.2%  
P/CF ratio (eoy) x20.1-13.9 -145.3%  
Price / Book Value ratio x4.03.7 108.2%  
Dividend payout %32.20-   
Avg Mkt Cap Rs m2,233,36145,919 4,863.7%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m82,9602,882 2,878.6%   
Avg. sales/employee Rs Th03,696.8-  
Avg. wages/employee Rs Th0671.3-  
Avg. net profit/employee Rs Th0-931.5-  
INCOME DATA
Net Sales Rs m438,85715,870 2,765.3%  
Other income Rs m8,199111 7,377.0%   
Total revenues Rs m447,05515,982 2,797.3%   
Gross profit Rs m112,900-2,750 -4,105.1%  
Depreciation Rs m25,294685 3,692.8%   
Interest Rs m1,720430 400.1%   
Profit before tax Rs m94,084-3,754 -2,506.3%   
Minority Interest Rs m0-10 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,476235 3,613.4%   
Profit after tax Rs m85,608-3,999 -2,140.7%  
Gross profit margin %25.7-17.3 -148.5%  
Effective tax rate %9.0-6.2 -144.2%   
Net profit margin %19.5-25.2 -77.4%  
BALANCE SHEET DATA
Current assets Rs m398,61911,624 3,429.3%   
Current liabilities Rs m199,0646,540 3,043.8%   
Net working cap to sales %45.532.0 142.0%  
Current ratio x2.01.8 112.7%  
Inventory Days Days147111 132.6%  
Debtors Days Days95124 76.8%  
Net fixed assets Rs m376,9606,775 5,563.6%   
Share capital Rs m2,39974 3,256.2%   
"Free" reserves Rs m557,5550-   
Net worth Rs m559,95412,457 4,495.3%   
Long term debt Rs m04,377 0.0%   
Total assets Rs m775,79423,531 3,296.8%  
Interest coverage x55.7-7.7 -720.4%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.60.7 83.9%   
Return on assets %11.3-15.2 -74.2%  
Return on equity %15.3-32.1 -47.6%  
Return on capital %17.1-19.8 -86.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m82,5410-   
CASH FLOW
From Operations Rs m49,5931,355 3,661.0%  
From Investments Rs m-79,437-416 19,098.0%  
From Financial Activity Rs m23,7613,973 598.1%  
Net Cashflow Rs m1,1554,912 23.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.36 Rs / ZAR

Compare SUN PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SUN PHARMA With: CONCORD BIOTECH  ADVANCED ENZYME TECHNOLOGIES  SURYA PHARMA  AVON ORGANIC  EVEREST ORGANICS  



Today's Market

Gift Nifty Up 73 Points | Tata Consumer Q4 Results & Interim Dividend | M&M Finance Delays Q4 Results | Top Buzzing Stocks Today Gift Nifty Up 73 Points | Tata Consumer Q4 Results & Interim Dividend | M&M Finance Delays Q4 Results | Top Buzzing Stocks Today(Pre-Open)

Indian share markets continued the momentum as the session progressed and ended the higher.